Raymond James Downgrades bluebird bio (BLUE) to Market Perform
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $0.91 -1.09%
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Raymond James analyst Dane Leone downgraded bluebird bio (NASDAQ: BLUE) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.
Shares of bluebird bio closed at $80.45 yesterday.
You May Also Be Interested In
- BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds bluebird bio, Inc. Investors of Upcoming Deadline
- Wedbush Downgrades First Industrial Realty Trust (FR) to Neutral
- Goldman Sachs Downgrades Parade Technologies Ltd. (4966:TT) to Sell
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
